glp-1/gip dual agonist lilly Efficacy and safety of a novel GIP and GLP-1 receptor tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Eli Lilly's New $299 Month-Long

Entering my second month on Tirzepatide injection and doing great on it

At Florida Surgery & Weight Loss Center, we offer expert, provider-guided peptide therapies with comprehensive medical supervision and support

GLP-1s for weight management are now accounting for an average of 10.5% of total annual claims for employers in 2025, up from 8.9% in 2024 and 6.9% in 2023

In published preclinical research, GHK-Cu has been examined across in vitro fibroblast and keratinocyte cultures (PMID 19319546, PMID 23019153), murine wound-healing and tissue-remodelling models (PMID 38879894, PMID 39902373), and broader gene-expression-profiling work in cell culture (PMID 28212278, PMID 29986520)

Nanomedicine 19, 51395156

Case Studie Exemple How Can You Handle Dihexa Peptide API Raw Powder Without Damaging It